Page last updated: 2024-08-26

sr141716 and Hepatic Encephalopathy

sr141716 has been researched along with Hepatic Encephalopathy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avraham, Y; Berry, EM; Dagon, Y; Gabbay, E; Ganzburg, V; Ilan, Y; Israeli, E; Magen, I; Mechoulam, R; Okun, A; Pappo, O; Silberman, I; Vorobia, L; Zolotarev, O	1

Other Studies

1 other study(ies) available for sr141716 and Hepatic Encephalopathy

Article	Year
Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiology of disease, 2006, Volume: 21, Issue:1 Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cognition; Dose-Response Relationship, Drug; Endocannabinoids; Female; Glycerides; Hepatic Encephalopathy; Liver; Liver Failure, Acute; Maze Learning; Mice; Mice, Inbred Strains; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Thioacetamide	2006

Article

Year

Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice.

Neurobiology of disease, 2006, Volume: 21, Issue:1

Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cognition; Dose-Response Relationship, Drug; Endocannabinoids; Female; Glycerides; Hepatic Encephalopathy; Liver; Liver Failure, Acute; Maze Learning; Mice; Mice, Inbred Strains; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Thioacetamide

2006